MDxHealth Q1 Revenues Climb 66 Percent | GenomeWeb

NEW YORK (GenomeWeb) – MDxHealth reported today a 66 percent increase in first quarter revenues as the company benefitted from the inclusion of its ConfirmMDx prostate cancer test in the 2016 National Comprehensive Cancer Network (NCCN) guidelines.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.